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Introduction. Bloom syndrome (BS) is an inherited disorder due to mutation in BLM gene. The diagnosis of BS should be
considered in patients with growth retardation of prenatal onset, a photosensitive rash in a butterfly distribution over the cheeks,
and an increased risk of cancer at an early age. Clinical manifestations also include short stature, dolichocephaly, prominent ears,
micrognathia, malar hypoplasia and a high-pitched voice, immunodeficiency, type II diabetes, and hypogonadism associated with
male infertility and female subfertility.The aim of this report is to describe case of patient with BS who developed adenocarcinoma
of the cecum, successfully treated by right colectomy. Case Report. A 40-year-old man underwent colonoscopy to investigate the
cause of his diarrhea, weight loss, and anemia.The patient knew that he was a carrier of BS diagnosed at young age.The colonoscopy
showed an expansive and vegetating mass with 5.5 cm in diameter, located within the ascending colon. Histopathological analysis
of tissue fragments collected during colonoscopy confirmed the presence of tubular adenocarcinoma, and he was referred for
an oncological right colectomy. The procedure was performed without complications, and the patient was discharged on the
fifth postoperative day. Histopathological examination of the surgical specimen confirmed the presence of a grade II tubular
adenocarcinoma (stage IIA). The patient is currently well five years after surgery, without clinical or endoscopic signs of relapse in
a multidisciplinary approach for the monitoring of comorbidities related to BS. Conclusion. Despite the development of colorectal
cancer to be, a possibility rarely described the present case shows the need for early screening for colorectal cancer in all patients
affected by BS.
1. Introduction
Bloom syndrome (BS) is an extremely rare autosomal reces-
sive genetic disorder caused by a mutation in the BLM
gene encoding a DNA repair enzyme homology to the
RecQ helicases that receives the same name of the gene
[1, 2]. The absence of BLM protein activity leads to a
DNA repair defect, which causes increased risk of mutations
[2, 3]. The main clinical features in the BS include short
stature, dolichocephaly (long, narrow head), sun-sensitive
malar telangiectatic erythema, and immune deficiency, low
birth weight, prenatal and postnatal retardation of the
growth development, prominent ears, micrognathia, congen-
ital telangiectatic erythema in face, type II diabetes, male
infertility and female subfertility, immunodeficiency, upper
respiratory recurrent infections, and an increased risk of
cancer at an early age [4, 5].
One of the reasons for the interest in this rare syndrome
is the great risk to development of malignancies at various
sites, most commonly breast, gastrointestinal tract, and skin
[6]. Patients with BS are estimated to develop malignancy at
a rate 150–300 times higher than the general population and
about 25% of them develop malignancy, at a mean age of 20.7
years [6, 7]. This increased risk of cancer leads to a shortened
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Figure 1: Basal cell carcinoma in forehead.
life expectancy and patients with BS rarely survived after
their fifties [2]. Approximately 12% of BS patients can develop
colon cancer, and themean age at diagnosis is 35.4 years [2, 8].
The aim of this report is to present a patient with a BS who
developed colon cancer at 40 years of age.
2. Case Report
A34-year-old-man, with a previous history of recurrent chest
infections, presented with a six-month history of diarrhea,
abdominal pain specially located in the right lower quadrant,
asthenia, lack of appetite, and weight loss (5 kg). He was the
second child of four children and referred that one of his
brother died at the age of 40 years by liver failure devoid
hepatic metastasis of colorectal cancer. He reports type II
diabetes making use of metformin. During the adolescence
he had been hospitalized on four occasions for the treatment
of pulmonary infection. The patient reports that he had
recently been referred for surgical resection of a skin tumor
with 1.5 cm in diameter located on the forehead (Figure 1).
The lesion was removed a week after its diagnosis and the
histopathological study confirmed the presence of a basal cell
carcinoma. He was born in Brazil and their ancestors do not
belong to Ashkenazi ethnicity.
At admission, physical examination showed a short
stature (142 cm), weight of 48 kg, growth retardation,
dolichocephaly, triangular face, beaked nose, prominent
ears (Figure 2(a)), and hypogonadism. He had a high-
pitched voice, small mandible, dystrophic nails, clinodactyly
(Figure 2(b)), and palmar transverse crease (Figure 2(c)).
He had a telangiectatic erythema in malar region of the face
and forehead that worsened after solar radiation and a linear
scar in brow related to previous surgical resection of a basal
cell carcinoma (Figure 2(d)). He also presents with several
cafe´ au lait macules in the abdominal skin and gluteal region
(Figure 3).
Abdominal examination revealed palpable mobile mass
in the right lower quadrant. Blood tests revealed hypoalbu-
minemia at 1.8 g/L, glycemia at 280mg/dL, and hypochromic
microcytic anemia at 8.4 g/dL. Renal and hepatic biochemical
tests were normal. The suspect of BS was confirmed by chro-
mosomic analysis showing chromosomal breakages and sis-
ter chromatid exchanges. Upper gastrointestinal endoscopy
was normal and colonoscopy revealed a polypoid-ulcerated
mass located in ascending colon (Figure 4). Biopsies speci-
mens of the mass confirmed a well-differentiated adenocar-
cinoma. Computed tomography scan of the abdomen and
pelvis only showed the cecal mass without hepatic metastasis
or regional lymph node enlargement.
With a diagnosis of ascending colon adenocarcinoma he
was submitted to an open oncological right colectomy. He
had uneventful recovery and was discharged on the 5th day.
The histopathological examination confirmed the diagnosis
of tubular adenocarcinoma without neoplastic involvement
in 23 lymph nodes resected (stage IIA). The revision of
histopathology slide of the tumor located on forehead
confirmed the previous diagnosis of basal cell carcinoma.
The patient was instructed to daily use sunscreen on all
skin surfaces exposed to solar radiation. He was referred
to surveillance program of the digestive tract neoplasms,
performing colonoscopy and upper endoscopy every year. At
this time the patient is well, with no signs of recurrence of the
colon cancer or polyps five years after colectomy.
3. Discussion
BS also known as congenital telangiectatic erythema is a rare,
autosomal recessive genetic disorder found in humans and
experimentalmodels [6, 9, 10].The disease was first described
in New York City, in 1954, by David Bloom, a Polish-
born dermatologist, as a congenital telangiectatic erythema
resembling lupus erythematosus in dwarfs [9, 11].
BS is caused by mutations in BLM gene located in chro-
mosome 15 (15q26.1) that comprises 4,437 base pairs, which
encodes a protein BLM with 1,417 amino acids homology
to the RecQ helicases [12]. Thisprotein restores breaks in
double-stranded DNA and is the only known RecQL helicase
that can unwind asingle-stranded DNA sequence of four
consecutive guanines [13]. The absence of BLM activity leads
to a DNAdefect repair, which causes genomic instability with
increased rates of chromosomal breakage, rearrangements,
genemutation, and increase of the risk of cancer development
[3]. The most characteristic cytogenetic features in BS is
the 15-fold increased rate of sister chromatid exchanges
and this increased level is a pathognomic feature of BS [7,
14]. The transmission of BS is autosomal recessive, and a
homozygous state is fundamental for clinical manifestation
1. Heterozygous carriers usually are asymptomatic; however
a link between heterozygous carrier status and increased risk
of colorectal and breast cancer has been established [1, 15, 16].
The syndrome was initially reported in the Ashkenazi
Jewish population. The BLM gene mutation is known to be
highly prevalent among Ashkenazi population, where the
carrier state is estimated to bemore than 1 : 110 to 1 : 231 [1, 17–
19]. The BS population has been monitored since 1960 via
Bloom’s SyndromeRegistry (BSR) and the data is periodically
updated [20]. Actually data collected in 2009 from the BSR
showed 265 persons with BS are from 222 families (sibships)
[11]. This data also showed that of the 265 cases collected of
the BS only 21 (7.9%) patients live in South America and 16
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Figure 2: (a) Dolichocephaly, beaked nose, and prominent ears. (b) Clinodactyly and dystrophic nails. (c) Palmar transverse crease. (d)
Telangiectatic erythema and linear scar in forehead due to previous surgical excision of basal cell carcinoma.
Figure 3: Cafe´ au lait macules in the anterior abdominal skin.
(6.03%) in Brazil [11].The patient of this report did not belong
to the Judaic ethnicity.
The hallmark of the clinical presentation of BS is charac-
teristic with marked retardation of the growth development
and an early onset photosensitive facial rash that worsened
with solar exposition [1]. Data fromBSR evaluating the height
in 95 patients showed that themeans inmenwas 149 cm (128–
164) while in women was 138 cm (115–160) [11]. The patient
described in this report had height of 142 cm, staying within
the described mean of the BSR data. The malar telangiectatic
erythema of patients with BS usually more intensely affects
skin exposed to solar irradiation. Similarly to that found
Figure 4: Polypoid-ulcerated mass in ascending colon.
in patients with lupus, the erythema of the patients with
BS compromises more frequently the face, especially malar
region. The erythema may also compromise the skin of the
forehead, as occurs in the patient of this report, ears, lips, and
neck [7, 9, 16]. These injuries worsened after sun exposure
that can form painful superficial skin ulcers. To prevent the
worsening of the telangiectatic erythema and to avoid the
increased risk of basal cell carcinoma, as occurs in the patient
of this report BS patients need to daily use sunscreen.German
reviewing the first 100 cases of BS found eight cases of skin
cases and only three cases associated with colorectal cancer
[6]. Therefore, the simultaneity of colorectal cancer and skin
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cancer is a not common association. Other skin lesions are
described in patients with BS. The presence of cafe´ au lait
macules mainly located in the trunk is described as found in
the patient of this report [7]. Old scars can also be identified
at the sites where prevailing telangiectatic erythema resulted
from healing of sun exposure ulcers.
Patients with BS generally present with a small but
proportionate body, associated dolichocephaly, kneel-shaped
face, sharp nose, and low-set ears giving those affected
characteristic facies a high-pitched voice, features also on
the patient in this case [1, 6]. Type II diabetes mellitus and
recurrent respiratory infections are described generally at
young age [6, 17]. The patient of this report was referred
treatment for type II diabetes since age of 23 years and four
previous hospital admissions to treat pneumonia. Repetitive
lung infections are related to immunodeficiency often found
in patients with BS. Men with BS present with genital
hypoplasia and oligospermia. There are reports of adult
female patients with BS with a history of normal childbirth,
but, generally, the subfertility is a rule [21].
Themost significant implication of a diagnosis of BS from
the patient’s point of view is the high risk of developing cancer
[1, 6]. Patients with BS have an increased risk of developing a
variety of malignancies, notably leukemia, lymphomas, and
carcinomas of various sites, that is high from the twenties
onwards, which is the case of our patient. The course of life
in these patients is made remarkable by early onset single or
multiple neoplasias involving any organ system, which is the
main cause of mortality. Many patients will have more than
one cancer andmost will die by the third decade of life [6, 22].
Newer data indicate that BLMmutations contribute to breast
cancer susceptibility, and heterozygous carriers of a BLM
mutation have a higher probability of developing colorectal
cancer [15, 16, 23]. Among the most serious complications
that patients with BS develop lifelong, malignant neoplasms
of different locations are the most frequent, accounting for
46%, followed by type II diabetes (15.8%) and lung infections
(2.6%) [11]. BSR data showed that of 265 patients followed
122 (46.3%) developed cancer [11]. Of those patients 69
(56.5%) were men and 53 (43.4%) women. Epithelial tumors
are the most frequent type (52.5%), followed by lymphoid
(24.9%) and hematopoietic neoplasm (11.3%) [11]. Different
types of neoplasms are described in about 12% of patients.
Acute leukemia and lymphomas seem to predominate in the
first two decades of life and carcinomas, mainly located on
gastrointestinal tract, more common after the second decade
[24]. Tumors that are rare in the general population, such
osteosarcoma, medulloblastoma, andWilms’ tumor are more
common in patients with BS [9].
About 12% of BS patients develop colorectal cancer,
usually from the second decade of life and the median age
at diagnosis is 35.4 years, similar to that occurring in patient
of this report [8, 24]. German in 1997 analyzing the first
100 cases of cancer on the BSR found 13 cases of colorectal
cancer, seven in proximal colon (cecum, ascending, hepatic
flexure, and transverse) and six in distal colon (descending,
sigmoid, and rectum) [6]. Since then, we can only find
three other published cases, two with fatal course [2, 8, 9].
Although the occurrence of skin cancer in patients with
BS is well documented in the worldwide literature, the
finding of primary skin carcinoma occurring concomitant
with colorectal cancer, to the best of our knowledge, only two
cases, has been reported [2, 6].
The best surgical approach of colorectal cancer in carriers
BS is still controversial. As these patients have an increased
risk for developing a second malignance at young age, some
authors recommend conducting a proctocolectomy [2]. If
the patient refuses the total colectomy partial colectomy
and annual follow-up colonoscopy for colon and rectum
remaining can be offered. In patient of this report, we discuss
the advantages and disadvantages of the two surgical options,
and the patient opted for the realization of the right colectomy
with annual follow-up. So far, this strategy seemed to us
valid because the annual colonoscopic and upper endoscopy
monitoring conducted in the last five years did not find
any suspicious lesion. This is the first BS case associated
with colon and basal cell skin cancer that has been reported
in Brazilian population. It is important to recognize this
rare condition in order to diagnose the disease at an early
stage and tailor the treatment regimen to try to avoid the
development of malignances. A screening program should
therefore be offered, particularly for upper gastrointestinal,
breast, and colon cancer.
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